A splice isoform signature of Parkinson’s disease in peripheral blood
Ontology highlight
ABSTRACT: In these studies, we used splice variant-specific microarrays manufactured by the ExonHit company ( www.exonhit.com) on the Affymetrix platform. The goal was to identify splice isoforms whose expression is altered in whole blood of early-stage Parkinson’s disease patients compared to healthy and neurodegenerative disease controls. The study included 19 cases of Parkinson’s disease (PD) samples, 4 of multiple system atrophy (MSA), 4 progressive supranuclear palsy (PSP) and 10 healthy controls. Thirteen splice variants were confirmed in quantitative polymerase chain reactions and used to classify blinded samples from Parkinson’s disease patients and controls with 90% accuracy and 94% sensitivity.
ORGANISM(S): Homo sapiens
PROVIDER: GSE34287 | GEO | 2012/12/01
SECONDARY ACCESSION(S): PRJNA149951
REPOSITORIES: GEO
ACCESS DATA